Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.

scientific article

Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DIABETES.49.6.1064
P698PubMed publication ID10866061
P5875ResearchGate publication ID12452874

P50authorJacob GeorgeQ73291725
P2093author name stringKeren G
Harats D
Goldberg I
Kopolovic J
Levkovitz H
Shaish A
Keren P
Afek A
Janakovic Z
P433issue6
P407language of work or nameEnglishQ1860
P921main subjecthyperglycemiaQ271993
hyperlipidemiaQ1079120
atherosclerosisQ12252367
P304page(s)1064-1069
P577publication date2000-06-01
P1433published inDiabetesQ895262
P1476titleEffect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.
P478volume49

Reverse relations

cites work (P2860)
Q59366309Acute hyperglycemia in uterine arteries from pregnant, but not non-pregnant mice, enhances endothelium-dependent relaxation
Q26822630Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches
Q35179999Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.
Q33321055Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol
Q37316205BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis
Q42725544Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters
Q43423547Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence
Q36016914Deletion of GαZ protein protects against diet-induced glucose intolerance via expansion of β-cell mass
Q92196955Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions
Q37486465Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions
Q53486855Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs.
Q47693851Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice
Q37653826Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization
Q24530027Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
Q55355643Hyperglycemia does not affect tissue repair responses in shear stress-induced atherosclerotic plaques in ApoE-/- mice.
Q80523271Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression
Q35061758Impairment of nitrergic system and delayed gastric emptying in low density lipoprotein receptor deficient female mice.
Q81686367Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus
Q40752499Left and right ventricular systolic function impairment in type 1 diabetic young adults assessed by 2D speckle tracking echocardiography.
Q44517931Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy
Q43687605Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis
Q83880274Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice
Q37040804Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population
Q36416215Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?
Q52666460SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice.
Q39951404Why does diabetes increase atherosclerosis? I don't know!

Search more.